Oslo, Norway, April 2, 2025 - The Board of Directors of Nykode Therapeutics ASA
(OSE: NYKD) hereby calls for an Extraordinary General Meeting (EGM) to be held
at meeting room FORUM - Building H, Floor 0 in Gaustadalléen 21, Oslo, Norway at
14:00 CEST on April 23, 2025. 

The purpose of the meeting is to elect a new Board of Directors. 

The notice of the EGM is attached. All documents regarding the EGM will also be
made available at the Company's website:
https://nykode.com/investors/shareholder-meetings/

For further information, please see the Company's website or contact the Company
at IR@nykode.com


This information is subject to the disclosure requirements pursuant to sections
5-12 of the Norwegian Securities Trading Act.